世界中医药
文章摘要
引用本文:刘红旭.经皮冠状动脉介入治疗(PCI)围手术期心肌损伤中医诊疗专家共识解读[J].世界中医药,2016,(03):.  
经皮冠状动脉介入治疗(PCI)围手术期心肌损伤中医诊疗专家共识解读
Consensus of Traditional Chinese Medicine Specialists on Percutaneous Coronary Intervention (PCI) Perioperative Myocardial Injury
投稿时间:2016-02-24  
DOI:10.3969/j.issn.1673-7202.2016.03.001
中文关键词:  PCI围手术期心肌损伤  专家共识  中医药
English Keywords:PCI perioperative myocardial injury  Expert consensus  Traditional Chinese medicine
基金项目:国家自然科学基金项目(编号:81273741),北京市科委十病十药课题(编号:Z141100002214010),北京市教委科技计划项目(编号:KM201310025027),首都医学科研发展基金重点攻关项目(编号:2014-1-2231)
作者单位
刘红旭 首都医科大学附属北京中医医院北京100010 
摘要点击次数: 1828
全文下载次数: 2247
中文摘要:
      经皮冠状动脉介入治疗(Percutaneous Coronary Intervention,PCI)是治疗冠心病的重要方法之一,但PCI围手术期心肌损伤(Peri-procedure Myocardial Injury,PMI)的发生严重影响患者的获益,而传统中医药在PCI围手术期心肌损伤的防治方面具有一定优势。为了提高中医药防治PCI围手术期心肌损伤的水平,规范冠心病PCI术后中医药干预治疗策略,世界中医药学会联合会介入心脏病学专家委员会、中华中医药学会介入心脏病专业委员会、中国医师协会中西医结合介入心脏病专家委员会组织相关专家,历时1年余制定了《经皮冠状动脉介入治疗(PCI)围手术期心肌损伤中医诊疗专家共识》(以下简称《共识》),并于2016年度中国介入心脏病学大会发布。作者对《共识》的核心内容做一解读。
English Summary:
      Percutaneous Coronary intervention is one of the major methods in treating coronary heart disease. However, Peri-procedure myocardial injury (PMI) can bring negative effect on the health of patients. In eliminating such effects, traditional Chinese medicine (TCM) has great advantage. To improve the curative effect of TCM as well as standardize the treating strategies, experts in cardiopathy from World Federation of Chinese Medicine Societies, China Association of Chinese Medicine, and Chinese Medical Doctor Association co-published “Consensus of Traditional Chinese Medicine Specialists on Percutaneous Coronary Intervention (PCI) Perioperative Myocardial Injury” after one-year’s dedication, and issued it on 2016 China Interventional Therapeutics Conference. This article aims at interpreting the core content of the Consensus.
查看全文  查看/发表评论  下载PDF阅读器